AC
SHPH icon

Ayrton Capital’s Shuttle Pharmaceuticals SHPH Stock Holding History

Ayrton Capital’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$134K Sell
110
-15
-12% -$24.7K 0.91% 16
2023
Q2 		$289K Buy
+125
New +$308K 1.8% 12

Other funds holding SHPH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ayrton Capital's SHPH Position: Q3 2023 in Review

Ayrton Capital reduced its Shuttle Pharmaceuticals (SHPH) stake by 12% in Q3 2023, selling an estimated $24.7K and leaving 110 shares worth $134K. The position accounts for 0.91% of the portfolio, ranked #16.

Ayrton Capital first reported a position in SHPH in Q2 2023 and has held it in 2 quarters since. The position peaked at $289K in Q2 2023. 3 funds tracked by Wall St. Rank hold SHPH as of Q3 2023.

  • Ayrton Capital held 110 shares of Shuttle Pharmaceuticals worth $134K as of Q3 2023.
  • Ayrton Capital sold 15 Shuttle Pharmaceuticals shares in Q3 2023, an estimated $24.7K.
  • Shuttle Pharmaceuticals made up 0.91% of Ayrton Capital's portfolio in Q3 2023, its #16 holding.
  • Ayrton Capital first reported a position in Shuttle Pharmaceuticals in Q2 2023 and has held it in 2 quarters since.
  • Ayrton Capital's Shuttle Pharmaceuticals position peaked at $289K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q3 2023.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.